Related Experiment Video
Updated: Feb 8, 2026

Pharmacological and Functional Genetic Assays to Manipulate Regeneration of the Planarian Dugesia japonica
Published on: August 31, 2011
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological
Luna Colagrossi1, Romina Salpini2, Rossana Scutari3
1Department of Experimental Medicine and Surgery, Tor Vergata University, 00133 Rome, Italy. luna_colagrossi@yahoo.it.
Insights
Hepatitis D virus (HDV) infection constrains Hepatitis B virus surface antigen (HBsAg) evolution, with conserved regions in both HBsAg and Hepatitis D antigen (HDAg) offering potential therapeutic targets for treating chronic HDV infection.
Area of Science:
- Virology
- Hepatology
- Molecular Biology
Background:
- Chronic co-infection with Hepatitis B virus (HBV) and Hepatitis D virus (HDV) significantly increases the risk of severe liver disease, including cirrhosis and hepatocellular carcinoma, compared to HBV mono-infection.
- Currently, no specific antiviral drugs targeting HDV are available in clinical practice, highlighting an unmet medical need for novel therapeutic strategies.
Purpose of the Study:
- To identify conserved and variable regions within Hepatitis B surface antigen (HBsAg) and Hepatitis D antigen (HDAg) domains in patients with chronic HBV + HDV co-infection.
- To provide a molecular basis for designing innovative therapeutic agents targeting HDV infection by analyzing genetic variability.
Main Methods:
- Amino acid variability was quantified using Shannon Entropy (Sn) analysis on HBsAg sequences from HBV + HDV infected and HBV mono-infected patients, and on HDAg sequences.
- Conserved positions were defined as those with Sn = 0. Statistical comparisons were performed between co-infected and mono-infected groups, with stratification for HBeAg status and patient age.
Main Results:
- A significantly higher percentage of conserved HBsAg positions was observed in HBV + HDV co-infection compared to HBV mono-infection (p = 0.001).
- Specific conserved C-terminal HBsAg positions correlated with higher HDV-RNA levels, suggesting a role in maintaining HDV fitness.
- HDAg exhibited a lower percentage of conserved residues than HBsAg (p < 0.001), indicating greater functional plasticity, although specific HDAg mutations correlated with increased HDV replication.
Conclusions:
- HDV co-infection imposes evolutionary constraints on HBsAg to maintain HDV fitness, indicating a complex host-pathogen interaction.
- The identification of conserved regions within HDAg, particularly the virus-assembly signal, provides a foundation for developing novel therapeutic targets against HDV infection.
Abstract:
Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection. However, to-date no direct anti-HDV drugs are available in clinical practice. Here, we identified conserved and variable regions in HBsAg and HDAg domains in HBV + HDV infection, a critical finding for the design of innovative therapeutic agents. The extent of amino-acid variability was measured by Shannon-Entropy (Sn) in HBsAg genotype-d sequences from 31 HBV + HDV infected and 62 HBV mono-infected patients (comparable for demographics and virological-parameters), and in 47 HDAg genotype-1 sequences. Positions with Sn = 0 were defined as conserved. The percentage of conserved HBsAg-positions was significantly higher in HBV + HDV infection than HBV mono-infection (p = 0.001). Results were confirmed after stratification for HBeAg-status and patients’ age. A Sn = 0 at specific positions in the C-terminus HBsAg were correlated with higher HDV-RNA, suggesting that conservation of these positions can preserve HDV-fitness. Conversely, HDAg was characterized by a lower percentage of conserved-residues than HBsAg (p < 0.001), indicating higher functional plasticity. Furthermore, specific HDAg-mutations were significantly correlated with higher HDV-RNA, suggesting a role in conferring HDV replicative-advantage. Among HDAg-domains, only the virus-assembly signal exhibited a high genetic conservation (75% of conserved-residues). In conclusion, HDV can constrain HBsAg genetic evolution to preserve its fitness. The identification of conserved regions in HDAg poses the basis for designing innovative targets against HDV-infection.
Related Concept Videos
The Evidence for Evolution
Convergent Evolution
What is Population Genetics?
Animal Mitochondrial Genetics
Eukaryotic Evolution
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Synteny and Evolution
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...

